This statistic shows the net income of biotechnology company Biogen from 2007 to 2024. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2024, Biogen generated a net income worth around 1.63 billion U.S. dollars.

Biogen reported $240.5M in Net Income for its fiscal quarter ending in March of 2025. Data for Biogen | BIIB - Net Income including historical, tables and charts were last updated by Trading Economics this last June in 2025.

This statistic shows the revenue and net income of biotechnology company Biogen from 2007 to 2024. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2024, Biogen generated revenues worth around 9.7 billion U.S. dollars.

Biogen Net Gelir - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.Data for Biogen | Net Gelir including historical, tables and charts were last updated by Trading Economics this last May in 2025.

Biogen PE ratio as of May 06, 2025 is 7.20. Current and historical p/e ratio for Biogen (BIIB) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biogen Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jun 2025.Data for Biogen | Dochód Netto including historical, tables and charts were last updated by Trading Economics this last June in 2025.

Biogen Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.Data for Biogen | Nettoeinkommen including historical, tables and charts were last updated by Trading Economics this last April in 2025.

The graph compares the annual net incomes of major pharmaceutical companies in the United States for the years 2010 and 2022. The x-axis lists the companies, including Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Sanofi, Novartis, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Biogen, Viatris, and Takeda Pharmaceutical. The y-axis represents net income in billions of U.S. dollars. In 2010, Johnson & Johnson led with the highest net income of $13.34 billion, while Viatris had the lowest at $0.224 billion. By 2022, Pfizer's net income surged to $31.37 billion, becoming the highest, whereas AstraZeneca and Takeda Pharmaceutical saw significant declines to $3.29 billion and $2.05 billion, respectively. Most companies, such as GlaxoSmithKline, Merck, and AbbVie, experienced substantial increases in net income over the twelve-year period. However, some companies like Novartis and AstraZeneca faced reductions in their earnings. The data is presented in a grouped bar chart format, highlighting the changes in annual net income for each pharmaceutical company between 2010 and 2022.

Biogen 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2025.Data for Biogen | 净收入 including historical, tables and charts were last updated by Trading Economics this last June in 2025.

In 2022, Biogen generated almost 350 thousand U.S. dollars’ worth of net profit per employee, which ranked the company second among the global top 15 pharmaceutical companies. Net profit per employee data can be used as an indicator to gauge how profitable a company (or industry) is.

Biogen

Biogen is a biotechnology & pharmaceutical company, based in Massachusetts, United States, specialized in developing medical solutions for neurological and neurodegenerative diseases. In 2022, Biogen had an average of over 8,700 people employed.

Pharmaceutical giants

Today, some of the largest corporations in the pharma industry include Johnson & Johnson, Novartis, Pfizer, and Roche, to name a few. Based on market capitalization worldwide, Eli Lilly led the list as of October 2023, with a market cap of roughly 500 billion U.S. dollars. In terms of 2022 prescription sales numbers, Roche stood in sixth place with about 48 billion U.S. dollars, while placed first in the R&D rankings, spending almost 15 billion dollars on research and development.

Biogen درآمد خالص - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Jun 2025.Data for Biogen | درآمد خالص including historical, tables and charts were last updated by Trading Economics this last June in 2025.

Biogen Чистый Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.Data for Biogen | Чистый Доход including historical, tables and charts were last updated by Trading Economics this last May in 2025.

Biogen 당기 순이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Jun 2025.Data for Biogen | 당기 순이익 including historical, tables and charts were last updated by Trading Economics this last June in 2025.

Biogen Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2025.Data for Biogen | Nettoindtægt including historical, tables and charts were last updated by Trading Economics this last April in 2025.

Biogen Nettoinkomst - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.Data for Biogen | Nettoinkomst including historical, tables and charts were last updated by Trading Economics this last April in 2025.

Biogen 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jun 2025.Data for Biogen | 当期純利益 including historical, tables and charts were last updated by Trading Economics this last June in 2025.

Biogen صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.Data for Biogen | صافي الدخل including historical, tables and charts were last updated by Trading Economics this last May in 2025.

Biogen Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.Data for Biogen | Revenu Net including historical, tables and charts were last updated by Trading Economics this last April in 2025.

Biogen Nettó Jövedelem - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2025.Data for Biogen | Nettó Jövedelem including historical, tables and charts were last updated by Trading Economics this last April in 2025.

Biogen Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.Data for Biogen | Lngresos Netos including historical, tables and charts were last updated by Trading Economics this last June in 2025.